Insurers face long road, high coverage cost
A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk‘s …
Eli Lilly and Co
Here’s what is behind the stock market’s selloff and what we’re doing about it
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Stocks sink Eli Lilly surges …
Novavax (NVAX) Q2 2023 earnings report
Medical syringes and Novavax logo displayed in the background are seen in this illustration photo taken in Krakow, Poland on December 2, 2021. Jakub Porzycki | NurPhoto | Getty Images …
Eli Lilly (LLY) Q2 2023 earnings report
Sopa Images | Lightrocket | Getty Images Eli Lilly on Tuesday raised its full-year guidance as second-quarter profit jumped 85% from the same period a year ago on strong sales …
5 things to know before the stock market opens Monday
Here are the most important news items that investors need to start their trading day: 1. Markets look to rebound Stock futures inched higher Monday after a down stretch. The …
Inflation takes center stage in the week ahead as Wall Street looks for more clues on Fed rate hikes
New inflation data set for release in the week ahead could help Wall Street regain its footing. The latest read on the consumer price index — an inflation gauge that …
Here are the 5 price-target changes and 4 trades we made during this busy earnings week
In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for some of our biggest stocks. Many of these moves stemmed from what we saw …
These health-care companies see opportunity ahead from Alzheimer’s drug approval
As patients with Alzheimer’s disease seek out a newly approved treatment, they will need MRIs, blood tests and other diagnostics, fueling increased demand for these important tools. In earnings calls …
This early stage biotech may be next play on obesity drug boom
The lucrative market for obesity drugs is dominated by two players right now, but Structure Therapeutics has the potential to enter the category with an oral GLP-1 medication, according to …
Obesity drug from Eli Lilly helped boost weight loss to 26%
The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, September 17, 2020. Mike Blake | Reuters An Eli Lilly experimental drug helped patients …